bpc 157 human clinical evidence Peptide BPC-157 BPC-157 - Research Grade Peptide
Description
Bardoxolone methyl (BAR), an Nrf2 agonist, mitigates inflammation by activating nuclear factor erythroid-derived 2-related factor 2 (Nrf2) and inhibiting NF-B, thereby decreasing mitochondrial ROS production and preventing the NF-B-mediated release of pro-inflammatory cytokines through the upregulation of antioxidant enzymes
Inflammation Acute inflammation is necessary to fight infections and repair damaged tissue
Contraindications Absolute contraindications: - Wilson's disease or any copper metabolism disorder
Storage: Store at controlled room temperature of 20C to 25C (68F to 77F)
Li, D., Field, P
